NCT07748559Completed
Impact of High-Oleic Palm Oil Consumption on Cardiovascular Biomarkers in Adults in Bogotá
Effect of Domestic Consumption of High Oleic Palm Oil on Cardiovascular Risk Biomarkers in Adults in Bogotá, DC
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
This randomized clinical trial aims to evaluate the effects of refined high-oleic palm oil consumption on cardiovascular risk biomarkers and insulin resistance in healthy adults. Participants will be randomly assigned to two groups to consume either high-oleic palm oil or olive oil for four months in typical domestic preparations.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 27 Jul 2026
- Start date
- 22 Oct 2024
- Primary completion date
- 27 Sept 2025
- Lead sponsor
- Ruby Alejandra Villamil
- Diseases
- Type 2 diabetes
- NCT number
- NCT07748559
What you commit to
- Study type: Interventional
- Participants enrolled: 52
- From 22 Oct 2024 to the primary completion date, 27 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- o Use of nutritional supplements
- Uncontrolled chronic diseases (e.g., diabetes, chronic kidney disease)
- Allergies to palm oil or olive oil
Who the study is looking for
- Adults aged ≥18 years
- Stable medication dosages (if applicable)
- Signed informed consent
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pontificia Universidad Javerian Coordinator of this site? Confirm its status | Bogotá | Colombia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.